| 查看: 265 | 回复: 4 | |||||
| 【奖励】 本帖被评价3次，作者jessie7527增加金币 2.5 个 | |||||
| 当前主题已经存档。 | |||||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||||
[资源]
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)
|
|||||
|
Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development) By Wei Dai Publisher: Humana Press Number Of Pages: 314 Publication Date: 2008-05-01 ISBN-10 / ASIN: 1588299309 ISBN-13 / EAN: 9781588299307 Binding: Hardcover Extensive research has uncovered a set of molecular surveillance mechanisms – commonly called “checkpoints” – which tightly monitor cell-cycle processes. Today’s anticancer drug development has identified many of these cell-cycle checkpoint molecules as effective targets. Research now promises to uncover a new generation of anticancer drugs with improved therapeutic indices based on their ability to target emerging checkpoint components. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs. This book’s distinguished panel of authors takes a close look at topics ranging from the major molecular players affecting DNA synthesis and the response to DNA damage to advances made in the identification of chemical compounds capable of inhibiting individual mitotic kinases. Illuminating and authoritative, Checkpoint Responses in Cancer Therapy offers a critical summary of findings for researchers in the pharmaceutical and biotechnology industries and a valuable resource for academic scientists in cancer research and the study of cell-cycle regulation, signal transduction and apoptosis. http://rapidshare.com/files/1120 ... _Cancer_Therapy.pdf |
回复此楼» 猜你喜欢
投稿Elsevier的Neoplasia杂志，到最后选publishing options时页面空白，不能完成投稿
已经有15人回复
-
职称评审没过，求安慰
已经有13人回复
-
毕业后当辅导员了，天天各种学生超烦
已经有4人回复
-
EST投稿状态问题
已经有4人回复
-
聘U V热熔胶研究人员
已经有10人回复
-
求助文献
已经有3人回复
-
垃圾破二本职称评审标准
已经有10人回复
-
投稿返修后收到这样的回复，还有希望吗
已经有8人回复
-
三无产品还有机会吗
已经有6人回复
-
谈谈两天一夜的“延安行”
已经有13人回复